Home LiteratureArticle Details
PMID: 2537066 Published · ppublish English Case Reports Journal Article

Tamoxifen withdrawal response. Report of a case.

Archives of internal medicine ·Vol. 149 ·No. 2 ·1989-02-00 ·Pages 449-50

Belani CP, Pearl P, Whitley NO, Aisner J

Abstract

A postmenopausal patient with breast cancer with a left infrahilar lung mass was treated with tamoxifen. She became asymptomatic, but after having stable disease for eight months, she developed progressive increase in the size of the mass necessitating tamoxifen withdrawal. Complete resolution of the mass occurred following withdrawal of tamoxifen. Withdrawal responses, though known to occur with additive hormonal treatment, especially complete regression of metastatic disease as seen in our patient, is not widely recognized. Thus, when clinically possible, patients should be observed off treatment for up to six weeks, before initiating a new therapeutic modality.

MeSH Terms
Breast Neoplasms/drug therapy Carcinoma, Intraductal, Noninfiltrating/drug therapy,secondary Female Humans Lung Neoplasms/drug therapy,secondary Lymphatic Metastasis Menopause Middle Aged Remission Induction Substance Withdrawal Syndrome Tamoxifen/administration & dosage
Chemicals
Tamoxifen
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Belani C P
University of Maryland Cancer Center, Baltimore 21201.
Pearl P
Whitley N O
Aisner J
Article Info
Journal
Archives of internal medicine
Abbr.
Arch Intern Med
ISSN
0003-9926
Published
1989-02-00
Pages
449-50
Language
English
Region
United States
NLM ID
0372440
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com